Literature DB >> 772896

Histamine changes in Plasmodium falciparum malaria.

T Srichaikul, N Archararit, T Siriasawakul, T Viriyapanich.   

Abstract

Histamine, serum complement factor 3 (C'3) and platelets were studied in 33 Plasmodium falciparum patients. Elevation of histamine level in the blood was found during acute infection but was more marked in the group of patients with systemic complications. A correlation between histamine changes, clinical complications, reduction of C'3 and degree of thrombocytopenia was observed. The possible role of histamine in the development of complications in P. falciparum infection and the possible release of this substance through the activation of complement system and immune destruction of platelets were discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 772896     DOI: 10.1016/0035-9203(76)90004-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

1.  Severe orthostatic hypotension during treatment of falciparum malaria.

Authors:  J M Kofi Ekue; D E Phiri; M Mukunyandela; U K Sheth; W H Wernsdorfer
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-06

2.  Mast cells and histamine alter intestinal permeability during malaria parasite infection.

Authors:  Rashaun A Potts; Caitlin M Tiffany; Nazzy Pakpour; Kristen L Lokken; Connor R Tiffany; Kong Cheung; Renée M Tsolis; Shirley Luckhart
Journal:  Immunobiology       Date:  2015-11-25       Impact factor: 3.144

3.  Immune mimicry in malaria: Plasmodium falciparum secretes a functional histamine-releasing factor homolog in vitro and in vivo.

Authors:  S M MacDonald; J Bhisutthibhan; T A Shapiro; S J Rogerson; T E Taylor; M Tembo; J M Langdon; S R Meshnick
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

Review 4.  Dynamic interactions of Plasmodium spp. with vascular endothelium.

Authors:  Mark R Gillrie; May Ho
Journal:  Tissue Barriers       Date:  2016-12-07

5.  Enhanced basophil reactivities during severe malaria and their relationship with the Plasmodium falciparum histamine-releasing factor translationally controlled tumor protein.

Authors:  Stéphane Pelleau; Sylvie Diop; Méry Dia Badiane; Joana Vitte; Pierre Beguin; Farida Nato; Bernard M Diop; Pierre Bongrand; Daniel Parzy; Ronan Jambou
Journal:  Infect Immun       Date:  2012-07-02       Impact factor: 3.441

6.  Malaria-associated L-arginine deficiency induces mast cell-associated disruption to intestinal barrier defenses against nontyphoidal Salmonella bacteremia.

Authors:  Jennifer Y Chau; Caitlin M Tiffany; Shilpa Nimishakavi; Jessica A Lawrence; Nazzy Pakpour; Jason P Mooney; Kristen L Lokken; George H Caughey; Renee M Tsolis; Shirley Luckhart
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

7.  Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria.

Authors:  Adeline Porcherie; Cedric Mathieu; Roger Peronet; Elke Schneider; Julien Claver; Pierre-Henri Commere; Hélène Kiefer-Biasizzo; Hajime Karasuyama; Geneviève Milon; Michel Dy; Jean-Pierre Kinet; Jacques Louis; Ulrich Blank; Salaheddine Mécheri
Journal:  J Exp Med       Date:  2011-10-03       Impact factor: 14.307

8.  Histamine Ingestion by Anopheles stephensi Alters Important Vector Transmission Behaviors and Infection Success with Diverse Plasmodium Species.

Authors:  Anna M Rodriguez; Malayna G Hambly; Sandeep Jandu; Raquel Simão-Gurge; Casey Lowder; Edwin E Lewis; Jeffrey A Riffell; Shirley Luckhart
Journal:  Biomolecules       Date:  2021-05-11

9.  Duality and complexity of allergic type inflammatory mechanisms in determining the outcome of malaria disease.

Authors:  Ulrich Blank; Salaheddine Mécheri
Journal:  Front Immunol       Date:  2011-12-23       Impact factor: 7.561

10.  Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease.

Authors:  Walid Beghdadi; Adeline Porcherie; Bradley S Schneider; David Dubayle; Roger Peronet; Michel Huerre; Takeshi Watanabe; Hiroshi Ohtsu; Jacques Louis; Salaheddine Mécheri
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.